Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

64.76 -1.38 (-2.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,342,073
Open 67.03
Bid (Size) 64.70 (1)
Ask (Size) 65.00 (1)
Prev. Close 66.14
Today's Range 63.59 - 69.99
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
(VKTX) - Analyzing Viking Therapeutics's Short Interest
Via Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY. 
Via Talk Markets

Performance

YTD
+254.27%
+254.27%
1 Month
+25.24%
+25.24%
3 Month
+2.78%
+2.78%
6 Month
+84.08%
+84.08%
1 Year
+350.66%
+350.66%

More News

Read More
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
Via Benzinga
Could Viking Therapeutics Become the Next Novo Nordisk?
Via The Motley Fool
3 Promising Biotech Stocks for the Long-Term: August 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
Via The Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
Via The Motley Fool
3 Unstoppable Stocks to Buy in August
Via The Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Via The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
Via InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
Via The Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
Via InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
Via The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
Via The Motley Fool
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Is Viking Therapeutics a Millionaire-Maker Stock?
Via The Motley Fool
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.